Pipotiazine palmitate
- Level
- Commodity
- Parent
- 51332800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51332868This classification denotes a dopamine antagonist with the molecular formula C40H63N3O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4Q3H01QRMI, chemically known as 10-(3-(4-(2-hydroxyethyl)piperidino)propyl)-n,n-dimethylphenothiazine-2-sulfonamide palmitate (ester) but more generally known as pipotiazine palmitate, which bears US NIH Compound Identifier 37767. European Medicines Agency schedules Pipotiazine palmitate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03860MIG. Most nations, for tariff and trade purposes, schedule pipotiazine palmitate under HS 29350090 and SITC 51580. As of Q4 2014, PIPOTIAZINE PALMITATE remains US FDA's Preferred Term for this commodity. Pipotiazine palmitate bears US NLM identifiers UMLS ID C0770895 and NCI Concept Code C87712. SMILES: CCCCCCCCCCCCCCCC(=O)OCCC1CCN(CC1)CCCN2C3CCCCC3SC4C2CC(CC4)S(=O)(=O)N(C)C.
Same parent
Under 51332800 · 79Activities that produce or sell this
KBLI · 8Inherited from family 51330000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.